| Title |
Randomized Clinical Trial Examining the Impact of Lactobacillus rhamnosus GG Probiotic Supplementation on Cognitive Functioning in Middle-aged and Older Adults
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, November 2020
|
| DOI | 10.2147/ndt.s270035 |
| Pubmed ID | |
| Authors |
Victoria Sanborn, M Andrea Azcarate-Peril, John Updegraff, Lisa Manderino, John Gunstad |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 12% |
| United Kingdom | 2 | 8% |
| Switzerland | 1 | 4% |
| Poland | 1 | 4% |
| Australia | 1 | 4% |
| United States | 1 | 4% |
| Unknown | 17 | 65% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 62% |
| Practitioners (doctors, other healthcare professionals) | 5 | 19% |
| Scientists | 5 | 19% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 109 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 14% |
| Student > Master | 7 | 6% |
| Researcher | 6 | 6% |
| Other | 5 | 5% |
| Professor | 3 | 3% |
| Other | 9 | 8% |
| Unknown | 64 | 59% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 7% |
| Agricultural and Biological Sciences | 5 | 5% |
| Nursing and Health Professions | 5 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Other | 14 | 13% |
| Unknown | 68 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2024.
All research outputs
#928,965
of 25,383,278 outputs
Outputs from Neuropsychiatric Disease and Treatment
#121
of 3,129 outputs
Outputs of similar age
#24,682
of 430,006 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 38 outputs
Altmetric has tracked 25,383,278 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,129 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,006 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.